Connection

Viswanathan Ramakrishnan to Hydroxamic Acids

Back to Details
This is a "connection" page, showing publications Viswanathan Ramakrishnan has written about Hydroxamic Acids.
Viswanathan Ramakrishnan
Connection Strength
0.026
Hydroxamic Acids
  1. A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2. Clin Cancer Res. 2013 Apr 01; 19(7):1873-83.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.